Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
A phase 1 trial of intravenous 4-( N -( S -glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours
FEBS Lett Watanabe N, Matsumoto S, Suzuki S, Fukaya T, Kato Y, Hashiya N (2020) Effect of Ergothioneine on the Cognitive Function Improvement in Healthy Volunteers and Mild Cognitive Impairment Subjects A Randomized, Doubleblind, Parallelgroup Comparison Study
Thinning temples and crown
Settlements and Litigation Strategy: While defending its product, Novo Nordisk has also engaged in strategic settlements in some cases to mitigate legal risks and public relations fallout
Aug 20 2010;70(12):1487-503
US$ 27.21
US$ 21.21
US$ 22.78
